This inventor holds 1 USPTO granted patent. Top assignee: Lupin, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations of Ashok Bhau Pathak
Introduction
Ashok Bhau Pathak is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptor activities. His work is characterized by a focus on innovative solutions for managing various diseases and disorders.
Latest Patents
One of Ashok Bhau Pathak's key patents is related to Bicyclic GPR119 modulators. This invention involves compounds of Formula (I) that are useful for treating, preventing, and managing diseases associated with the modulation of GPR119 receptor activity. The patent also details the process for preparing these compounds and their pharmaceutical compositions. Furthermore, it outlines methods for treating conditions linked to GPR119 receptor modulation using these compounds, either alone or in combination.
Career Highlights
Ashok Bhau Pathak is currently associated with Lupin, Inc., a prominent player in the pharmaceutical industry. His role at the company allows him to leverage his expertise in drug development and innovation. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in medical science.
Collaborations
Throughout his career, Ashok has collaborated with talented individuals such as Onkar Gangaram Kachi and Atish Harishchandra Rodge. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Ashok Bhau Pathak's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of GPR119 modulators, highlight the importance of research and development in addressing health challenges. His ongoing efforts at Lupin, Inc. continue to pave the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
